April 28, 2008 - CVRx introduced a new device for high blood pressure engineered to treat hypertension patients whose conditions are not controlled by drugs, and aims to reduce systolic blood pressure.

Rheos Hypertension (HT) Therapy, which is now in clinical trials, is an implantable device and uses the body's natural blood pressure sensor (the baroreflex) to reduce blood pressure. Early hypertension clinical trial results showed a 39 mmHg reduction in systolic blood pressure at one year of use.

InfraReDx Inc. developed the LipiScan Coronary Imaging System that is intended to characterize fatty deposits in coronary vessel walls using near infrared diffuse spectroscopy.

Medtronic's Defender embolic protection filter, available in Europe, is a device designed to get rid of emboli that can occur during a variety of stenting procedures.

Nihon Kohden America Inc. provides a Prefense Early Detection and Notification System, an early detection and notification system, has received 510K clearance from the FDA, paving the way for immediate release to customers.

Prefense is designed to protect hospital patients from medical harm and enhance the efficiency of Rapid Response Teams. Prefense is unique as it allows hospital patients to freely ambulate while measuring heart rate, blood pressure, oxygen saturation and respiration - four of the seven critical parameters that trigger a rapid response team.

The VeinViewer by Luminetx is a vascular imaging system that allows physicians, nurses and other healthcare professionals to clearly see accessible vasculature (or lack thereof) in real time. The company will highlight the product at the product at the American Association of Critical Care Nurses Conference May 6-7 in Chicago.

April 28, 2008 – A study of clinical trials involving artificial blood substitutes has shown they can cause an increased in risk of death and heart attacks, according to an article this week in the Journal of the American Medical Association.

April 28, 2008 - Terumo Heart will present data on its DuraHeart LVAS, a circulatory support device intended to provide cardiac support for patients who are at risk of death due to end-stage left ventricular failure, which indicates the device provides safe and reliable long-term circulatory support with improved survival.

April 28, 2008 - Doctors at The National Brain Aneurysm Center in St. Paul, MN, use intraoperative angiography (IA) now in all of their surgical procedures as re-examination of the vascular anatomy may disclose a fundamental misinterpretation of the local anatomy on the part of the surgeon, which might lead to an error without the use of IA.

April 28, 2008 - Medtronic Inc. today said the FDA has cleared the OneTouch UltraLink Meter as the new wireless meter exclusively certified by Medtronic designed to wirelessly communicate with Medtronic diabetes management products in the U.S.

This new meter uses wireless technology to transmit glucose readings directly to MiniMed Paradigm insulin pumps and the Guardian REAL-Time Continuous Glucose Monitoring System. This makes bolus dosing more accurate and easier for patients compared to the manual entry of blood glucose readings.

April 28, 2008 - Minimally invasive heart robotic bypass surgery could lead to faster recoveries for patients and a greater likelihood of the new bypass vessels staying open, and may be more cost-effective, according to a University of Maryland study on robotic heart bypass surgery. The study, "Superior Financial and Quality Metrics with Robotically-assisted (DaVinci) Coronary Artery Revascularization," was presented at the 128th annual meeting of the American Surgical Association in New York on April 26, 2008.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now